5-Bromo-1,3-dihydrobenzoimidazol-2-one, 95.0%, 500g

9,9-Dimethyl-9H-fluoren-2-amine, 95.0%, 500g

1-methyl-2,4(1H,3H)-quinazolinedione, 95.0%, 1g

(R)-1-(3-ETHOXYPHENYL)ETHAN-1-AMINE, 95%, 100mg

5-Fluorosalicylic acid, 97.0%, 1g

3-Methoxy-3-methyl-1-butanol, min. 99%, for synthesis, 100 ml, glass packaging

4,5-Diphenyl-2-oxazolethiol>98.0%(HPLC)(T)5g

2-(4-Butylphenyl)propanoic acid, 97%, 50mg

tetrahydrofuran-3-yl chloridocarbonate, 95.0%, 500mg

Piperidine-1,4-dicarboxylic acid 1-benzyl ester 4-methyl ester, 95.0%, 50g

Methyl 4-((4-methylpiperazin-1-yl)methyl)benzoate, 95.0%, 5g

1,2,3,4-Tetrahydronaphthalene-1,5-diol, 95%, 100mg

({1-[4-fluoro-3-(trifluoromethyl)phenyl]-2,5-dimethyl-1H-pyrrol-3-yl}methyl)amine, 95.0%, 500mg